feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
trending

Arch Manning scores multiple TDs

trending

Penn State beats Nebraska

trending

Boise State defeats Colorado State

trending

Utah defeats Kansas State

trending

Duke defeats UNC football

trending

Pitt defeats Georgia Tech football

trending

LAFC vs Vancouver semifinal

trending

LSU leads Western Kentucky

trending

Kings vs Nuggets preview

Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2025 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Boy's unsteady walk reveals rare brain cancer

Boy's unsteady walk reveals rare brain cancer

19 Nov

•

Summary

  • A four-year-old boy's unsteady walking led to a brain cancer diagnosis.
  • His mother was diagnosed with breast cancer while he underwent treatment.
  • Family seeks US trial for preventative treatment not available in UK.
Boy's unsteady walk reveals rare brain cancer

A four-year-old boy named Raffi Starkowitz experienced an alarming change in his coordination, leading to an emergency hospital visit. Doctors discovered a mass on his brain, subsequently diagnosed as aggressive anaplastic medulloblastoma. Raffi underwent extensive surgery, chemotherapy, and radiotherapy. His family faced further hardship when his mother, Nicky, was diagnosed with stage three breast cancer during his treatment, requiring her own rigorous medical regimen.

Despite Raffi's scans showing no current disease, the risk of recurrence is high, with no preventative treatments available in the UK. This uncertainty prompted the family to seek experimental therapy abroad. Simultaneously, Nicky is undergoing chemotherapy for her breast cancer, adding immense emotional and logistical challenges for the family.

To access a clinical trial for a potential preventative drug, difluoromethylornithine (DFMO), Raffi has been accepted at a hospital in Pennsylvania, USA. The family is actively fundraising to cover the substantial costs associated with treatment, travel, and accommodation for this life-saving opportunity.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Raffi Starkowitz was diagnosed with group 3 large cell anaplastic medulloblastoma.
There are no preventative treatments available in the UK for his high-risk condition, so he is joining a US trial.
His parents are navigating Raffi's brain cancer and Nicky's breast cancer diagnosis simultaneously, seeking support and treatment options.

Read more news on

USAside-arrowHealthside-arrowPennsylvaniaside-arrow

You may also like

Grandmother's Cancer Fight: J&J Baby Powder Accused

20 hours ago • 10 reads

article image

Rare Brain Cancer Vanquished by Experimental Drugs

8 hours ago • 2 reads

article image

Botulism Outbreak Linked to Baby Formula

21 Nov • 34 reads

article image

NHS Offers New Hope for 1,500 Heart Patients

21 Nov • 15 reads

article image

Antibiotic Horror: 5 Months of Agony

20 Nov • 20 reads

article image